Una Revisión Empírica de los Dispositivos Clave de Monitoreo de Glucosa: Iteraciones de Producto y Protección de Patentes
PMID: 37272495 ·
J, o, n, a, t, h, a, n, , J, , D, a, r, r, o, w, ;, , V, i, c, t, o, r, , V, a, n, , d, e, , W, i, e, l, e, ;, , D, a, v, i, d, , B, e, r, a, n, ;, , A, a, r, o, n, , S, , K, e, s, s, e, l, h, e, i, m
Publicidad
Resumen
Each year, people with diabetes and their insurers or governments spend billions of dollars on blood glucose monitors and their associated components. These monitors have evolved substantially since their introduction in the 1970s, and manufacturers frequently protect original medical devices and their modifications by applying for and obtaining patent protection. We tracked the product iterations of five widely used blood glucose monitors-manufactured by LifeScan, Dexcom, Abbott, Roche, and Tri
Publicidad
Fuente oficial
Ver en PubMed →Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.